Related Experiment Video
Updated: May 1, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Vanin-1 inactivation antagonizes the development of adrenocortical neoplasia in Sf-1 transgenic mice
Perle Latre de Late1, Abeer El Wakil, Marielle Jarjat
1Institut de Pharmacologie Moléculaire et Cellulaire CNRS (P.L.D.L., A.E.W., M.J., E.L.) Valbonne 06560, France; Associated International Laboratory for the Study of the ALterations of Gene Expression in Childhood Cancers CNRS (P.L.D.L., A.E.W., M.J., E.L.), Valbonne 06560, France; Université de Nice-Sophia Antipolis (P.L.D.L., A.E.W., M.J., E.L.), Valbonne 06560, France; Department of Pathology (R.R.K.), Erasmus MC-University Medical Center, Rotterdam 3015, The Netherlands; Department of Molecular and Integrative Physiology (L.L.H.), University of Kansas Medical Center, Kansas City, Kansas 66160; Centre d'Immunologie de Marseille-Luminy (P.N.), Aix-Marseille University, UM2, Marseille, France; Institut National de la Santé et de la Recherche Médicale (P.N.), U1104, Marseille, France; and Centre National de la Recherche Scientifique (P.N.), UMR7280, Marseille, France.
Abstract:
SF-1 (NR5A1) overexpression can induce adrenocortical tumor formation in transgenic mice and is associated with more severe prognosis in patients with adrenocortical cancer. In this study we have identified Vanin-1 (Vnn1), a SF-1 target gene, as a novel modulator of the tumorigenic effect of Sf-1 overexpression in the adrenal cortex. Vanin-1 is endowed with pantetheinase activity, releasing cysteamine in tissues and regulating cell response to oxidative stress by modulating the production of glutathione. Sf-1 transgenic mice developed adrenocortical neoplastic lesions (both dysplastic and nodular) with a frequency increasing with age. Genetic ablation of the Vnn1 gene in Sf-1 transgenic mice significantly reduced the severity of neoplastic lesions in the adrenal cortex. This effect could be reversed by treatment of Sf-1 transgenic/Vnn1 null mice with cysteamine. These data show that alteration of the mechanisms controlling intracellular redox and detoxification mechanisms is relevant to the pathogenesis of adrenocortical neoplasia induced by SF-1 overexpression.
Insights
Steroidogenic factor 1 (SF-1) overexpression drives adrenal cancer. Targeting Vanin-1 (Vnn1), an SF-1 target gene, reduces tumor severity by modulating oxidative stress and glutathione production.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Steroidogenic factor 1 (SF-1) overexpression is linked to adrenocortical tumor formation and poor prognosis in adrenal cancer.
- SF-1 plays a crucial role in adrenal cortex development and function.
Purpose of the Study:
- To identify novel modulators of SF-1's tumorigenic effects in the adrenal cortex.
- To investigate the role of Vanin-1 (Vnn1) in SF-1-induced adrenocortical neoplasia.
Main Methods:
- Utilized SF-1 transgenic mice to study adrenocortical tumor formation.
- Generated SF-1 transgenic mice lacking the Vnn1 gene (SF-1/Vnn1 null).
- Administered cysteamine to SF-1/Vnn1 null mice to assess reversibility of effects.
Main Results:
- SF-1 transgenic mice developed age-dependent adrenocortical neoplastic lesions.
- Genetic ablation of Vnn1 significantly reduced the severity of these lesions.
- Cysteamine treatment reversed the protective effect of Vnn1 ablation, indicating Vnn1's role.
Conclusions:
- Vanin-1 (Vnn1), a SF-1 target gene, acts as a novel modulator of SF-1-induced adrenocortical tumorigenesis.
- Vnn1's pantetheinase activity, influencing cysteamine levels and glutathione production, is critical in this process.
- Altering redox and detoxification pathways is key in the pathogenesis of SF-1-driven adrenocortical neoplasia.
Related Concept Videos
In-vitro Mutagenesis
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

